(19)

(11)

EP 4 229 043 A1

(12)

(43) Date of publication: 23.08.2023 Bulletin 2023/34 (21) Application number: 21881315.2 (22) Date of filing: 14.10.2021

(51) International Patent Classification (IPC):  C07D 261/06(2006.01) A61K 31/445(2006.01) C07D 209/04(2006.01) C07D 261/02(2006.01) A61K 31/404(2006.01) C07D 209/02(2006.01) (52) Cooperative Patent Classification (CPC): C07D 413/14 (86) International application number: PCT/US2021/071862 (87) International publication number: WO 2022/082197 (21.04.2022 Gazette 2022/16)

(84) Designated Contracting States: AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR Designated Extension States: BA ME Designated Validation States: KH MA MD TN (30) Priority: 15.10.2020 US 202063092423 P (71) Applicant: Eli Lilly and Company Indianapolis, IN 46285 (US)	(72) Inventors: SWEETANA, Stephanie Ann Indianapolis, Indiana 46285 (US) SPROULL, Steven Jerald Indianapolis, Indiana 46285 (US) OWENS, Paul K. Indianapolis, Indiana 46285 (US) (74) Representative: Cooley (UK) LLP  22 Bishopsgate London EC2N 4BQ London EC2N 4BQ (GB)